Moderate LDL cholesterol reduction with statins shows similar benefit to aggressive lipid lowering in ischaemic heart diseaseBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i3437 (Published 22 June 2016) Cite this as: BMJ 2016;353:i3437
- Susan Mayor
Moderate reduction of low density lipoprotein (LDL) cholesterol with statins achieved similar reductions in adverse cardiac outcomes in patients with ischaemic heart disease to aggressive lipid lowering, shows a retrospective cohort study.1
The study, reported in JAMA Internal Medicine, compared the risk for major cardiac events in patients with ischaemic heart disease treated with statins and achieving a low LDL cholesterol level of ≤70 mg/dL with patients achieving moderate levels (70.1 to 100 mg/dL) or high levels (100.1 to 130 mg/dL) …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial